Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

816
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
816
Scientific Laws and Theories02:31

Scientific Laws and Theories

87.5K
Scientific Laws
87.5K
Subatomic Particles03:37

Subatomic Particles

112.4K
Dalton was only partially correct about the particles that make up matter. All matter is composed of atoms, and atoms are composed of three smaller subatomic particles: protons, neutrons, and electrons. These three particles account for the mass and the charge of an atom.
112.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphorylation of YBX1 in the Kidneys is Altered in Legumain Knockout-Mice.

Journal of proteome research·2026
Same author

PeptideVisualizer: A Novel Software Solution for PROTOMAP Analysis.

Journal of proteome research·2026
Same author

Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells.

Molecules (Basel, Switzerland)·2025
Same author

Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate-pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with <i>P</i>-glycoprotein.

Future medicinal chemistry·2025
Same author

Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance.

Oncology research·2025
Same author

Apoptotic Caspases-3 and -7 Cleave Extracellular Domains of Membrane-Bound Proteins from MDA-MB-231 Breast Cancer Cells.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jan 22, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.1K

Degradomics in Biomarker Discovery.

Marija Grozdanić1,2, Robert Vidmar1, Matej Vizovišek1

  • 1Department of Biochemistry, Molecular and Structural Biology, Jozef Stefan Institute, SI-1000, Ljubljana, Slovenia.

Proteomics. Clinical Applications
|July 11, 2019
PubMed
Summary
This summary is machine-generated.

Protease activity changes in disease. Monitoring these changes using degradomics can identify new biomarkers for diagnosis and treatment.

Keywords:
biomarkerdegradomicsproteaseproteomicssubstrate

More Related Videos

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

1.0K
Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.3K

Related Experiment Videos

Last Updated: Jan 22, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.1K
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

1.0K
Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.3K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Proteomics

Background:

  • Protease dysregulation is linked to diseases like cancer and neurodegeneration.
  • Proteolytic fragments in bodily fluids may serve as disease biomarkers.
  • Degradomics aims to globally identify protease activity and substrates.

Purpose of the Study:

  • Review recent advancements in degradomic methodologies.
  • Highlight the application of degradomics in biomarker discovery.
  • Discuss the clinical relevance and future of degradomics.

Main Methods:

  • Proteomic approaches for global identification of proteolytic events.
  • Advanced sample preparation for detecting protease substrates in complex samples.
  • Methodologies for identification and validation of proteolytic events.

Main Results:

  • Degradomics enables comprehensive analysis of protease activity.
  • Identification of specific cleaved proteins and peptides as potential biomarkers.
  • Established methods for detecting and validating protease-mediated cleavage.

Conclusions:

  • Degradomics offers powerful tools for understanding disease mechanisms.
  • Proteolytic biomarkers hold significant diagnostic and prognostic potential.
  • The field is advancing towards clinical applications for various diseases.